XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Stockholders' Equity Attributable to Fossil Group, Inc.
Stockholders' Equity Attributable to Fossil Group, Inc.
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Balance at beginning of period (in shares) at Dec. 29, 2018         49,518,000            
Balance at beginning of period at Dec. 29, 2018 $ 588,631 $ (29,468) $ 585,543 $ (29,468) $ 495 $ 268,113 $ 0 $ 381,626 $ (29,468) $ (64,691) $ 3,088
Increase (Decrease) in Shareholders' Equity                      
Common stock issued upon exercise of stock options, stock appreciation rights and restricted stock units (in shares)         1,302,000            
Common stock issued upon exercise of stock options and stock appreciation rights 170   170   $ 13 157          
Acquisition of common stock (4,197)   (4,197)     0 (4,197)        
Retirement of common stock (in shares)         (304,000)            
Retirement of common stock 0       $ (3) (4,194) 4,197        
Stock-based compensation 19,064   19,064     19,064          
Net income (loss) (50,012)   (52,365)         (52,365)     2,353
Other comprehensive income (loss) (15,924)   (15,924)             (15,924)  
Purchase of noncontrolling interest shares (562)   231     231         (793)
Distribution of noncontrolling interest earnings and other (3,861)   0             (3,861)
Balance at end of period (in shares) at Dec. 28, 2019         50,516,000            
Balance at end of period at Dec. 28, 2019 503,841   503,054   $ 505 283,371 0 299,793   (80,615) 787
Increase (Decrease) in Shareholders' Equity                      
Common stock issued upon exercise of stock options, stock appreciation rights and restricted stock units (in shares)         1,127,000            
Common stock issued upon exercise of stock options and stock appreciation rights 0   0   $ 11 (11)          
Acquisition of common stock (727)   (727)       (727)        
Retirement of common stock (in shares)         (169,000)            
Retirement of common stock 0       $ (1) (726) 727        
Stock-based compensation 11,143   11,143     11,143          
Net income (loss) (95,940)   (96,095)         (96,095)     155
Other comprehensive income (loss) $ 21,715   21,715             21,715  
Balance at end of period (in shares) at Jan. 02, 2021 51,474,034       51,474,000            
Balance at end of period at Jan. 02, 2021 $ 440,032   439,090   $ 515 293,777 0 203,698   (58,900) 942
Increase (Decrease) in Shareholders' Equity                      
Common stock issued upon exercise of stock options, stock appreciation rights and restricted stock units (in shares)         861,000            
Common stock issued upon exercise of stock options and stock appreciation rights 0   0   $ 8 (8)          
Acquisition of common stock (2,420)   (2,420)       (2,420)        
Retirement of common stock (in shares)         (189,000)            
Retirement of common stock 0       $ (2) (2,418) 2,420        
Stock-based compensation 9,497   9,497     9,497          
Net income (loss) 26,624   25,434         25,434     1,190
Other comprehensive income (loss) $ (8,375)   (8,375)             (8,375)  
Balance at end of period (in shares) at Jan. 01, 2022 52,145,738       52,146,000            
Balance at end of period at Jan. 01, 2022 $ 465,358   $ 463,226   $ 521 $ 300,848 $ 0 $ 229,132   $ (67,275) $ 2,132